Kisch Tobias, Weber Caroline, Rapoport Daniel H, Kruse Charli, Schumann Sandra, Stang Felix H, Siemers Frank, Matthießen Anna E
Department of Plastic Surgery and Hand Surgery, University of Lübeck, Lübeck, Germany.
Fraunhofer Research Institution for Marine Biotechnology, Lübeck, Germany.
PLoS One. 2015 Nov 13;10(11):e0142907. doi: 10.1371/journal.pone.0142907. eCollection 2015.
High numbers of adult stem cells are still required to improve the formation of new vessels in scaffolds to accelerate dermal regeneration. Recent data indicate a benefit for vascularization capacity by stimulating stem cells with lipopolysaccharide (LPS). In this study, stem cells derived from human skin (SDSC) were activated with LPS and seeded in a commercially available dermal substitute to examine vascularization in vivo. Besides, in vitro assays were performed to evaluate angiogenic factor release and tube formation ability. Results showed that LPS-activated SDSC significantly enhanced vascularization of the scaffolds, compared to unstimulated stem cells in vivo. Further, in vitro assays confirmed higher secretion rates of proangiogenic as well as proinflammatoric factors in the presence of LPS-activated SDSC. Our results suggest that combining activated stem cells and a dermal substitute is a promising option to enhance vascularization in scaffold-mediated dermal regeneration.
为了加速皮肤再生,仍需要大量的成体干细胞来改善支架中新血管的形成。最近的数据表明,用脂多糖(LPS)刺激干细胞对血管生成能力有益。在本研究中,用LPS激活来源于人皮肤的干细胞(SDSC),并将其接种到市售的真皮替代物中,以检测体内血管生成情况。此外,还进行了体外试验,以评估血管生成因子的释放和血管形成能力。结果表明,与体内未受刺激的干细胞相比,LPS激活的SDSC显著增强了支架的血管生成。此外,体外试验证实,在存在LPS激活的SDSC的情况下,促血管生成因子以及促炎因子的分泌率更高。我们的结果表明,将激活的干细胞与真皮替代物相结合是增强支架介导的皮肤再生中血管生成的一个有前景的选择。